semaglutide patent expiry date in India spurs generic drug boom When do the patents on

PlexusDx personalizes medication selection around your digestive constraints, ensuring you get effective therapy without unnecessary flare-up risk

doi: 10.1038/s41380-022-01436-7 40 CahoyJ

For smaller weight loss drug developers that may not have the risk appetite or resources to compete with larger players, the best way to cash in on a market dominated by two giants may be to pursue a partnership or acquisition

Literature has shown that GLP-1 agonists have a beneficial effect when changing impulsive behavior in AUD

The goal is to find a new way to treat addictions, which are a leading cause of sickness and death around the world